| Ident. | Authors (with country if any) | Title |
|---|
| 000312 (2020) |
Guido Iaccarino [Italie] ; Claudio Borghi [Italie] ; Arrigo F. G. Cicero [Italie] ; Claudio Ferri [Italie] ; Pietro Minuz [Italie] ; Maria Lorenza Muiesan [Italie] ; Paolo Mulatero [Italie] ; Giuseppe Mulè [Italie] ; Giacomo Pucci [Italie] ; Massimo Salvetti [Italie] ; Carmine Savoia [Italie] ; Leonardo Alberto Sechi [Italie] ; Massimo Volpe [Italie] ; Guido Grassi [Italie] | Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension |
| 000506 (2020) |
Li Runfeng [République populaire de Chine] ; Hou Yunlong [République populaire de Chine] ; Huang Jicheng [République populaire de Chine] ; Pan Weiqi [République populaire de Chine] ; Ma Qinhai [République populaire de Chine] ; Shi Yongxia [République populaire de Chine] ; Li Chufang [République populaire de Chine] ; Zhao Jin [République populaire de Chine] ; Jia Zhenhua [République populaire de Chine] ; Jiang Haiming [République populaire de Chine] ; Zheng Kui [République populaire de Chine] ; Huang Shuxiang [République populaire de Chine] ; Dai Jun [République populaire de Chine] ; Li Xiaobo [République populaire de Chine] ; Hou Xiaotao [République populaire de Chine] ; Wang Lin [République populaire de Chine] ; Zhong Nanshan [République populaire de Chine] ; Yang Zifeng [République populaire de Chine] | Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). |
| 000521 (2020) |
Maryam Fattahian [Iran] ; Mustafa Ghanadian [Iran] ; Zulfiqar Ali [États-Unis] ; Ikhlas A. Khan [États-Unis] | Jatrophane and rearranged jatrophane-type diterpenes: biogenesis, structure, isolation, biological activity and SARs (1984-2019). |
| 000792 (2020) |
Stephen J. Carter [États-Unis] ; Marissa N. Baranauskas [États-Unis] ; Alyce D. Fly [États-Unis] | Considerations for obesity, vitamin D, and physical activity amidst the COVID-19 pandemic. |
| 000A72 (2019) |
Henri Boullier [France] ; David Demortain [France] ; Maurice Zeeman [États-Unis] | Inventing Prediction for Regulation: The Development of (Quantitative) Structure-Activity Relationships for the Assessment of Chemicals at the US Environmental Protection Agency. |
| 000B02 (2019) |
Paul P. Geurink [Pays-Bas] ; Gerbrand J. Van Der Heden Van Noort [Pays-Bas] ; Monique P C. Mulder [Pays-Bas] ; Robert C M. Knaap [Pays-Bas] ; Marjolein Kikkert [Pays-Bas] ; Huib Ovaa [Pays-Bas] | Profiling DUBs and Ubl-specific proteases with activity-based probes. |
| 000B61 (2019) |
Matthew D. Newton [Royaume-Uni] ; Benjamin J. Taylor [Royaume-Uni] ; Rosalie P C. Driessen [Pays-Bas] ; Leonie Roos [Royaume-Uni] ; Nevena Cvetesic [Royaume-Uni] ; Shenaz Allyjaun [Royaume-Uni] ; Boris Lenhard [Royaume-Uni] ; Maria Emanuela Cuomo [Royaume-Uni] ; David S. Rueda [Royaume-Uni] | DNA stretching induces Cas9 off-target activity. |
| 000B98 (2018-06) |
L. Vereecken [Allemagne] ; B. Aumont [France] ; I. Barnes ; J. W. Bozzelli ; M. J. Goldman ; W. H. Green ; S. Madronich [États-Unis] ; M. R. Mcgillen ; A. Mellouki [France] ; J. J. Orlando [États-Unis] ; B. Picquet-Varrault [France] ; A. R. Rickard ; W. R. Stockwell ; T. J. Wallington ; W. P. L. Carter | Perspective on Mechanism Development and Structure-Activity Relationships for Gas-Phase Atmospheric Chemistry |
| 000C01 (2018) |
Dominik Dolles [Allemagne] ; Matthias Hoffmann [Allemagne] ; Sandra Gunesch [Allemagne] ; Oliviero Marinelli [Italie] ; Jan Möller [Allemagne] ; Giorgio Santoni [Italie] ; Arnaud Chatonnet [France] ; Martin J. Lohse [Allemagne] ; Hans-Joachim Wittmann [Allemagne] ; Andrea Strasser [Allemagne] ; Massimo Nabissi [Italie] ; Tangui Maurice [France] ; Michael Decker [Allemagne] | Structure–activity relationships and computational investigations into the development of potent and balanced dual-acting butyrylcholinesterase inhibitors and human cannabinoid receptor 2 ligands with pro-cognitive in vivo profiles |
| 000C19 (2018) |
Xueyi Lu [République populaire de Chine] ; Jiapei Yang [République populaire de Chine] ; Dongwei Kang [République populaire de Chine] ; Ping Gao [République populaire de Chine] ; Dirk Daelemans [Belgique] ; Erik De Clercq [Belgique] ; Christophe Pannecouque [Belgique] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | The discovery of novel diarylpyri(mi)dine derivatives with high level activity against a wide variety of HIV-1 strains as well as against HIV-2. |
| 000C31 (2018) |
Cy V. Credille [États-Unis] ; Benjamin L. Dick [États-Unis] ; Christine N. Morrison [États-Unis] ; Ryjul W. Stokes [États-Unis] ; Rebecca N. Adamek [États-Unis] ; Nicholas C. Wu [États-Unis] ; Ian A. Wilson [États-Unis] ; Seth M. Cohen [États-Unis] | Structure-Activity Relationships in Metal-Binding Pharmacophores for Influenza Endonuclease. |
| 000D30 (2017-09-19) |
Shilva Kayastha [France] | New methods of multiscale chemical space analysis : visualization of structure-activity relationships and structural pattern extraction |
| 000D40 (2017) |
Anindya Siddharta ; Stephanie Pfaender [Suisse] ; Nathalie Jane Vielle [Suisse] ; Ronald Dijkman [Suisse] ; Martina Friesland ; Britta Becker ; Jaewon Yang [Corée du Sud] ; Michael Engelmann ; Daniel Todt ; Marc P. Windisch [Corée du Sud] ; Florian H. Brill ; Joerg Steinmann ; Jochen Steinmann ; Stephan Becker [Allemagne] ; Marco P. Alves [Suisse] ; Thomas Pietschmann ; Markus Eickmann [Allemagne] ; Volker Thiel [Suisse] ; Eike Steinmann | Virucidal Activity of World Health Organization–Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses |
| 000D57 (2017) |
Cheng-Wei Yang [République populaire de Chine] ; Yue-Zhi Lee [République populaire de Chine] ; Hsing-Yu Hsu [République populaire de Chine] ; Chuan Shih [République populaire de Chine] ; Yu-Sheng Chao [République populaire de Chine] ; Hwan-You Chang [République populaire de Chine] ; Shiow-Ju Lee [République populaire de Chine] | Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity. |
| 000D60 (2017) |
Lu Yu [République populaire de Chine] ; Xiuhai Gan [République populaire de Chine] ; Dagui Zhou [République populaire de Chine] ; Fangcheng He [République populaire de Chine] ; Song Zeng [République populaire de Chine] ; Deyu Hu [République populaire de Chine] | Synthesis and Antiviral Activity of Novel 1,4-Pentadien-3-one Derivatives Containing a 1,3,4-Thiadiazole Moiety. |
| 000D63 (2017) |
Sumei Li [République populaire de Chine] ; Xiuhua Jia [République populaire de Chine] ; Xintian Shen [République populaire de Chine] ; Zhuwen Wei [République populaire de Chine] ; Zhiyan Jiang [République populaire de Chine] ; Yixian Liao [République populaire de Chine] ; Yiming Guo [République populaire de Chine] ; Xiaojun Zheng [République populaire de Chine] ; Guohua Zhong [République populaire de Chine] ; Gaopeng Song [République populaire de Chine] | Structure-activity relationships of 3-O-β-chacotriosyl oleanic acid derivatives as entry inhibitors for highly pathogenic H5N1 influenza virus. |
| 000D81 (2017) |
Abdo A. Elfiky [Égypte] ; Samah M. Mahdy [Égypte] ; Wael M. Elshemey [Égypte] | Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses. |
| 000F37 (2016) |
Gaopeng Song [République populaire de Chine] ; Xintian Shen [République populaire de Chine] ; Sumei Li [République populaire de Chine] ; Yibin Li [République populaire de Chine] ; Hongzong Si [République populaire de Chine] ; Jihong Fan [République populaire de Chine] ; Junhua Li [République populaire de Chine] ; Erqiang Gao [République populaire de Chine] ; Shuwen Liu [République populaire de Chine] | Structure-activity relationships of 3-O-β-chacotriosyl oleanane-type triterpenoids as potential H5N1 entry inhibitors. |
| 000F42 (2016) |
Bo Su [République populaire de Chine] ; Chunlong Cai [République populaire de Chine] ; Meng Deng [République populaire de Chine] ; Qingmin Wang [République populaire de Chine] | Spatial Configuration and Three-Dimensional Conformation Directed Design, Synthesis, Antiviral Activity, and Structure-Activity Relationships of Phenanthroindolizidine Analogues. |
| 001003 (2016) |
Jacob J. Swidorski [États-Unis] ; Zheng Liu [États-Unis] ; Zhiwei Yin [États-Unis] ; Tao Wang [États-Unis] ; David J. Carini [États-Unis] ; Sandhya Rahematpura [États-Unis] ; Ming Zheng [États-Unis] ; Kim Johnson [États-Unis] ; Sharon Zhang [États-Unis] ; Pin-Fang Lin [États-Unis] ; Dawn D. Parker [États-Unis] ; Wenying Li [États-Unis] ; Nicholas A. Meanwell [États-Unis] ; Lawrence G. Hamann [États-Unis] ; Alicia Regueiro-Ren [États-Unis] | Inhibitors of HIV-1 attachment: The discovery and structure-activity relationships of tetrahydroisoquinolines as replacements for the piperazine benzamide in the 3-glyoxylyl 6-azaindole pharmacophore. |
| 001049 (2016) |
Sheng Liu [République populaire de Chine] ; Yubin Li [République populaire de Chine] ; Wanxing Wei [République populaire de Chine] ; Kuiwu Wang [République populaire de Chine] ; Lisheng Wang [République populaire de Chine] ; Jianyi Wang [République populaire de Chine] | Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives. |
